C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Source: SEC Form 13F · as of Mar 2026C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors holds 16 biotech & pharma companies tracked by BioSniper, totaling $18.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$18.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 22,439 | $4.9M |
| JNJJOHNSON & JOHNSON | 11,458 | $2.8M |
| ABTABBOTT LABORATORIES | 19,573 | $2.0M |
| MCKMcKesson Corporation | 1,683 | $1.5M |
| PMPhilip Morris International Inc | 8,318 | $1.4M |
| LLYELI LILLY & Co | 1,487 | $1.4M |
| PFEPFIZER INC | 30,050 | $844K |
| MRKMerck & Co., Inc. | 6,637 | $798K |
| AMGNAMGEN INC | 1,967 | $692K |
| NVSNovartis AG | 3,325 | $508K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,157 | $313K |
| GILDGILEAD SCIENCES, INC. | 2,153 | $300K |
| DGXQuest Diagnostics Incorporated | 1,472 | $288K |
| BMYBRISTOL MYERS SQUIBB CO | 4,106 | $249K |
| ELVElevance Health Inc. | 758 | $222K |
| BHVNBiohaven Ltd. | 15,500 | $131K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.